Salix Dragon’s Blood Drug for Diarrhea Delayed by FDA
This article is for subscribers only.
Salix Pharmaceuticals Ltd., a maker of antibiotics and gastrointestinal drugs, said a decision by U.S. regulators on its new medicine to treat diarrhea in people with HIV has been postponed.
The Food and Drug Administration said it is still reviewing the company’s application to sell crofelemer tablets for patients with the virus that causes AIDS, according to a statement from the Raleigh, North Carolina-based company today. A decision on the treatment, which is derived from the Peruvian Dragon’s Blood tree, had been expected today.